ML
Mesoblast Ltd
🇺🇸XNAS.MESOUnited StatesHealthcare
$14.32USDdown -0.43 (-2.92%)ClosedDelayed11:25 PM
Price$14.32-0.43 (-2.92%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US5907174016
- CUSIP
- 590717104
Company
- Employees
- 108
- Headquarters
- Melbourne, United States
- Website
- https://www.mesoblast.com
- CEO
- Dr. Paul J. Simmons BSc, Ph.D.
Market
- Shares outstanding
- 129.9M
- Market cap
- $1.86B
Highlights
- Market cap
- $1.91B
- EPS LTM
- -$0.44calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- -32.34calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- 0%
Fundamentals (LTM)
- Revenue
- $120.79M+602.33%up year on year
- Net income
- -$57.5M+43.71%up year on year
- Gross margin
- 84.09%+140.33%up year on year
- Free cash flow
- -$42.36M+12.67%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.